IP Library › Granted Patent US 12,208,372
Granted Patent B2
US 12,208,372 · App. 16/472,747 · Granted Jan 28, 2025

Solid phase conditioning

Inventors: Nicolas Verbrugge (Loncin, BE); Xavier Y. A. Franci (Loncin, BE); Natthawadee Thawinwisan (Loncin, BE)
Assignee: GE HEALTHCARE LIMITED
B01J20/287B01D15/203B01D15/325C07B59/00B01J2220/62C07B2200/05
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,208,372
App. No.
16/472,747
Granted
Jan 28, 2025
Kind
B2
Abstract

The present invention relates to a method for conditioning reversed phase SPE cartridges that provides certain advantages compared with known such methods. The method of the invention finds particular use in the automated synthesis of radiolabeled compounds where SPE is used for example in the purification steps.

Claims (10)

1. A method to condition a tC18 reversed phase solid phase extraction (SPE) cartridge in an automated synthesizer cassette prior to trapping 18 F-FTAG on the SPE cartridge, wherein said method comprises the sequential steps of passing through said SPE cartridge:

(i) an inorganic solvent, wherein said inorganic solvent comprises NaOH;

(ii) a polar organic solvent, wherein the polar solvent comprises ethanol; and

(iii) a low-strength solvent, wherein the low-strength solvent comprises aqueous ethanol;

wherein steps (i)-(iii) occur at 35° C., the 18 F-FTAG is trapped on the SPE cartridge at 35° C., and

the uncorrected for decay end of synthesis (EOS) yield of 18 F-FDG is at least 77%.

2. The method as defined in claim 1 wherein said conditioning further comprises the following step (iv) of passing a low-strength solvent through said SPE cartridge wherein said low-strength solvent is selected from water or a buffer.

3. The method as defined in claim 1 wherein between 0.2-2.0 mL of said inorganic solvent is passed through said SPE cartridge in said conditioning step.

4. The method as defined in claim 1 wherein said method further comprised purification of a reaction mixture through the SPE cartridge to obtain the 18 F-FDG in a purified form.

5. The method as defined in claim 1 , wherein the SPE cartridge is flushed with nitrogen before step (ii) to remove residual inorganic solvent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2019
From: VERBRUGGE, NICOLAS; FRANCI, XAVIER Y.A.; THAWINWISAN, NATTHAWADEE
To: GE HEALTHCARE LIMITED
Reel/Frame 049559/0457 →
Priority Claims (1)
GB 1621864 · Dec 21, 2016 · national
Continuity (1)
Related Publication 20200047158A1 · Feb 13, 2020
References Cited (17)
US 8053622B2 · Osborn et al. · 2011 [cited by applicant]
US 9359288B2 · Svadberg et al. · 2016 [cited by applicant]
US 10869942B2 · Olberg · 2020 [cited by examiner]
US 20150139902A1 · Engell et al. · 2015 [cited by applicant]
US 20150259307A1 · Horn et al. · 2015 [cited by applicant]
US 20170217896A1 · Xu et al. · 2017 [cited by applicant]
US 20170313632A1 · Franci et al. · 2017 [cited by applicant]
CN 101146611A · 2008 [cited by applicant]
CN 104302658A · 2015 [cited by applicant]
CN 104507905A · 2015 [cited by applicant]
CN 106715397A · 2017 [cited by applicant]
CN 107108393A · 2017 [cited by applicant]
WO WO2014154886A1 · 2014 [cited by examiner]
WO 2016019285A1 · 2016 [cited by applicant]
Lemaire et al. J. Label Compd Radiopharm. 2002, 45, 435-447. (Year: 2002). [cited by examiner]
Office Action received in Chinese Application No. 201780086960.6 dated Jan. 7, 2022, with translation, 17 pages. [cited by applicant]
Search Report received in Chinese Application No. 201780086960.6 dated Dec. 29, 2021, with translation, 3 pages. [cited by applicant]